von Borstel & Associates’s GE HealthCare GEHC Stock Holding History

von Borstel & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-260	Closed	-$20K	–	69
2025 Q1	$20K	Buy	+260	New	+$22.3K	0.01%	113

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

von Borstel & Associates's GEHC Position: Q2 2025 in Review

von Borstel & Associates sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 260 shares — an estimated $20K sold.

von Borstel & Associates first reported a position in GEHC in Q1 2025 and held it in 1 quarter. The position peaked at $20K in Q1 2025. 1,311 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

von Borstel & Associates reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
von Borstel & Associates sold 260 GE HealthCare shares in Q2 2025, an estimated $20K.
von Borstel & Associates first reported a position in GE HealthCare in Q1 2025 and held it in 1 quarter.
von Borstel & Associates's GE HealthCare position peaked at $20K in Q1 2025.
1,311 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on von Borstel & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.